Published in Nephrol Dial Transplant on March 31, 2015
Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond. Nephrol Dial Transplant (2017) 0.75
Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy. PLoS One (2017) 0.75
Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res (2007) 4.53
Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol (2002) 4.23
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One (2011) 3.10
periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol (2005) 2.94
Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res (2008) 2.44
Pirfenidone for diabetic nephropathy. J Am Soc Nephrol (2011) 2.04
Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A (2010) 2.03
Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin Cancer Res (2005) 2.02
Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol (2001) 2.01
Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene (1995) 1.81
Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem (1998) 1.75
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res (2004) 1.65
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br J Cancer (2007) 1.53
Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia. Biochim Biophys Acta (2005) 1.49
Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal (2013) 1.45
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am J Pathol (2004) 1.39
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int (2011) 1.37
Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol (2003) 1.35
EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett (2000) 1.23
Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am J Physiol Renal Physiol (2008) 1.21
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci (2007) 1.21
Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol (2011) 1.19
Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. J Am Soc Nephrol (2006) 1.08
Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J Med Chem (2013) 1.08
Interaction of discoidin domain receptor 1 with collagen type 1. J Mol Biol (2007) 1.06
Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol (2005) 1.05
Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors. Neurosurgery (2000) 1.04
Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol (2011) 1.02
Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines. FASEB J (2001) 1.02
Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. Int Immunopharmacol (2008) 1.00
Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J (2012) 0.99
Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am J Pathol (2010) 0.99
Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology (2006) 0.99
Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol (2014) 0.98
Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant (2011) 0.97
Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One (2012) 0.95
The PDGF family in renal fibrosis. Pediatr Nephrol (2011) 0.94
Periostin is a collagen associated bone matrix protein regulated by parathyroid hormone. Matrix Biol (2010) 0.90
Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction. Kidney Int (2012) 0.89
Expression patterns and roles of periostin during kidney and ureter development. J Urol (2011) 0.89
Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem (2014) 0.88
Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients. Lupus (2015) 0.84
Imatinib: novel treatment of immune-mediated kidney injury. J Am Soc Nephrol (2013) 0.83
Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer? Cytokine Growth Factor Rev (2009) 0.82
Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc (2014) 0.80
Fibrosis, regeneration, and aging: playing chess with evolution. J Am Soc Nephrol (2011) 0.80
Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis. Perit Dial Int (2013) 0.76